Literature DB >> 8554567

A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells.

P C Reading1, C A Hartley, R A Ezekowitz, E M Anders.   

Abstract

The mechanism of lysis of influenza virus-infected BHK-21 cells by guinea pig serum (GPS) was investigated. Lysis was shown to involve activation of the classical complement pathway and was dependent on the presence of a mannose-binding lectin in GPS. FACS analysis demonstrated Ca(2+)-dependent binding of the lectin to influenza virus-infected, but not uninfected, cells. Cells infected with mutant strains of virus lacking a particular high-mannose oligosaccharide at the tip of the hemagglutinin molecule showed reduced binding of the lectin and were correspondingly less sensitive to lysis by GPS than cells infected with the parent viruses. The degree or pattern of glycosylation of influenza viruses thus influences susceptibility to this mechanism of viral clearance. By interfering with the infectious process, lectin-dependent complement-mediated lysis of infected cells may be an important component of innate immunity to influenza and other enveloped viruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554567     DOI: 10.1006/bbrc.1995.2886

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice.

Authors:  P C Reading; L S Morey; E C Crouch; E M Anders
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.

Authors:  Y Zhang; C Suankratay; X Zhang; D R Jones; T F Lint; H Gewurz
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

Review 4.  Virulence of influenza A virus for mouse lung.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

5.  Mannose-binding lectin codon 54 genetic polymorphism and vaginal protein levels in women with gynecologic malignancies.

Authors:  Nicole S Nevadunsky; Irina Korneeva; Thomas Caputo; Steven S Witkin
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-05-24       Impact factor: 2.435

6.  Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis.

Authors:  A F Swanson; R A Ezekowitz; A Lee; C C Kuo
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

7.  Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection.

Authors:  Wei-Chuan Chang; Mitchell R White; Patience Moyo; Sheree McClear; Steffen Thiel; Kevan L Hartshorn; Kazue Takahashi
Journal:  BMC Immunol       Date:  2010-12-23       Impact factor: 3.615

Review 8.  Soluble host defense lectins in innate immunity to influenza virus.

Authors:  Wy Ching Ng; Michelle D Tate; Andrew G Brooks; Patrick C Reading
Journal:  J Biomed Biotechnol       Date:  2012-05-16

9.  The "sweet" side of a long pentraxin: how glycosylation affects PTX3 functions in innate immunity and inflammation.

Authors:  Antonio Inforzato; Patrick C Reading; Elisa Barbati; Barbara Bottazzi; Cecilia Garlanda; Alberto Mantovani
Journal:  Front Immunol       Date:  2013-01-07       Impact factor: 7.561

10.  A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.

Authors:  Jutatip Panaampon; Nathamon Ngaosuwankul; Ornpreya Suptawiwat; Pirom Noisumdaeng; Kantima Sangsiriwut; Bunpote Siridechadilok; Hatairat Lerdsamran; Prasert Auewarakul; Phisanu Pooruk; Pilaipan Puthavathana
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.